While the abstract mentions GLP-1 has central actions and shares pathophysiological mechanisms with cognitive disorders through insulin resistance, the precise brain-specific mechanisms remain undefined. Understanding these pathways is critical for optimizing neuroprotective strategies. Gap type: open_question Source paper: GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes. (2023, Diabetes & metabolism, PMID:37657738)
Landscape Summary: What are the specific central mechanisms by which GLP-1 receptor agonists affect cognition? is a 0.76 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What are the specific central mechanisms by which GLP-1 receptor agonists affect cognition? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: